Properties of monoclonal antibodies against glycoproteins of western equine encephalitis virus. 1985

K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu

To analyze the biological activities of the alphavirus glycoproteins, eight different monoclonal antibodies against the two glycoproteins of western equine encephalitis virus were isolated. Five of the eight monoclonal antibodies were shown to be specific for E1 and three for E2 protein by an enzyme-linked immunosorbent assay and by radioimmunoprecipitation. Three of the five anti-E1 and all of the anti-E2 monoclonal antibodies inhibited hemagglutination by purified virions. One anti-E1 and two anti-E2 monoclonal antibodies possessed high virus-neutralizing activity.

UI MeSH Term Description Entries
D004667 Encephalitis Virus, Western Equine A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines in the United States, southern Canada, and parts of South America. Encephalomyelitis Virus, Western Equine,WEE Virus,Western equine encephalitis virus,Encephalitis Viruses, Western Equine,Virus, Western Equine Encephalitis,Viruses, Western Equine Encephalitis,Western Equine Encephalitis Viruses,WEE Viruses
D006384 Hemagglutination The aggregation of ERYTHROCYTES by AGGLUTININS, including antibodies, lectins, and viral proteins (HEMAGGLUTINATION, VIRAL). Hemagglutinations
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer

Related Publications

K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
April 2000, Hybridoma,
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
January 2024, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
January 1986, Microbiology and immunology,
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
January 2014, mAbs,
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
April 1982, The Journal of general virology,
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
August 1986, The Indian journal of medical research,
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
December 2018, Antibodies (Basel, Switzerland),
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
March 2005, Vaccine,
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
October 1982, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Yamamoto, and K Hashimoto, and J Chiba, and B Simizu
April 2015, Monoclonal antibodies in immunodiagnosis and immunotherapy,
Copied contents to your clipboard!